Ronald Heimark received his PhD in biochemistry from the University of California at Davis. Dr. Heimark was a Postdoctoral Fellow at the University of Washington in the Department of Biochemistry in Earl Davie’s laboratory investigating the initiation of blood coagulation. These studies were expanded in a second fellowshiin the cardiovascular biology laboratory of Stephen M. Schwartz in the Department of Pathology at the University of Washington. In 1990, Dr. Heimark was one of the scientific members that started the biotechnology company ICOS Corporation, which developed the product Cialis tadalafil) In 1993, Dr. Heimark left the biotechnology world and returned to academics at the University of Arizona. He has served on numerous NIH Study Sections and has published more than 80 publications.